Platform establishment to decrease non-specific plasma proteins/peptides applied with proteomic technology in tumor marker discovery.
碩士 === 長庚大學 === 醫學生物技術研究所 === 94 === In current biomarker study, the MALDI-TOF mass spectrometry is a powerful proteomic tool to search and identify differential expressed plasma proteins between normal and cancer patients. Especially, the low molecular weight plasma proteome/peptideome has been foc...
Main Authors: | Sung-Yi Wei, 魏上宜 |
---|---|
Other Authors: | Ann-Joy Cheng |
Format: | Others |
Language: | en_US |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/72966271185197305546 |
Similar Items
-
Discovery of tumor markers for gastric cancer by proteomics.
by: Jeng-Yih Wu, et al.
Published: (2014-01-01) -
Tumor potential markers discovery in hepatocellular carcinoma by proteomic approaches
by: Hung Su, et al.
Published: (2011) -
Automated Sample Preparation Platform for Mass Spectrometry-Based Plasma Proteomics and Biomarker Discovery
by: Vilém Guryča, et al.
Published: (2014-03-01) -
Precision-engineered Peptide and Protein Analogs: Establishing a New Discovery Platform for Potent GPCR Modulators
by: Kalyan Bharati Akondi, et al.
Published: (2021-06-01) -
Proteomic based approaches to marker discovery in renal cancer
by: Rogers, Mark Alan
Published: (2005)